De Novo device
Medline ART Skin Harvesting System
Medline Industries, Inc. · Semi-Automated Autologous Skin Graft Harvesting And Application Device (QYK, Class II) · First FDA decision Mar 27, 2024, newest Mar 27, 2024BurnsChronic wounds and ulcers
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
De Novo pathway
Device trials
1
Naming "Medline ART"
MAUDE reports
0
Brand "Medline ART", since 2015
PubMed studies
0
Mentioning "Medline ART"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Medline ART Skin Harvesting System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 1 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Application of Skin Substitute Grafts for Treatment of DFU and VLU of Lower ExtremitiesLocal determinationIn effectL36377First Coast Service Options, Inc.Updated Nov 21, 2019
Clinical trials
Device studies on ClinicalTrials.gov that name "Medline ART", any status and sponsor, newest update first.
- Microscopic Skin Tissue Column Grafting Technique Using the Autologous Regeneration of Tissue SystemStatus unknown
The Metis FoundationAcademic, hospital or other
NCT05324514 · 40 participants (planned) · Start Oct 1, 2022 · Primary completion Oct 2024
Device: High density microscopic skin tissue column grafting; Low density microscopic skin tissue column grafting · For: Wound of Skin; Burns
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Medline ART", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QYK
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Medline ART"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.